Judge Finds Purdue's OxyContin Patents Enforceable
A New York federal judge has found that Purdue Pharma LP did not engage in conduct that invalidated its patents for OxyContin in a ruling that the drug company claims severely...To view the full article, register now.
Already a subscriber? Click here to view full article